WallStreetZenWallStreetZen

NASDAQ: NVCT
Nuvectis Pharma Inc Stock Ownership - Who owns Nuvectis Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Nuvectis Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ron BentsurChairman CEO2024-05-141,940$6.74
$13.08kBuy
Shay ShemeshChief Dev. Ops. Officer2024-05-101,113$6.32
$7.03kBuy
Enrique PoradosuChief Science Business Off2024-05-10500$6.29
$3.15kBuy
Ron BentsurChairman CEO2024-05-102,000$6.40
$12.80kBuy
Ron BentsurChairman CEO2024-03-185,000$10.29
$51.45kBuy
Ron BentsurChairman CEO2023-10-10640$11.08
$7.09kBuy
Ron BentsurChairman CEO2023-10-09830$11.19
$9.29kBuy
Ron BentsurChairman CEO2023-10-06250$11.27
$2.82kBuy
Ron BentsurChairman CEO2023-10-051,400$11.09
$15.53kBuy
Ron BentsurChairman CEO2023-10-041,820$10.95
$19.93kBuy

1 of 5

NVCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCT insiders and whales buy or sell their stock.

NVCT Shareholders

What type of owners hold Nuvectis Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ron Bentsur17.69%3,246,424$19.97MInsider
Marlio Charles Mosseri14.14%2,595,000$15.96MInsider
Enrique Poradosu8.20%1,504,319$9.25MInsider
Shay Shemesh8.13%1,493,068$9.18MInsider
Blackrock Inc2.03%372,721$2.29MInstitution
Vanguard Group Inc1.63%298,800$1.84MInstitution
Baldwin Brothers LLC0.84%154,130$947.90kInstitution
Geode Capital Management LLC0.73%134,528$827.35kInstitution
State Street Corp0.70%129,379$795.68kInstitution
Kenneth Hoberman0.40%73,140$449.81kInsider

1 of 3

NVCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCT8.51%49.28%Net BuyingNet Buying
DBVT39.08%15.37%Net BuyingNet Buying
BLUE89.06%10.94%Net SellingNet Selling
ADAG22.30%0.00%
IMUX63.65%17.15%Net BuyingNet Buying
View Top Biotech Stocks

Nuvectis Pharma Stock Ownership FAQ

Who owns Nuvectis Pharma?

Nuvectis Pharma (NASDAQ: NVCT) is owned by 8.51% institutional shareholders, 49.28% Nuvectis Pharma insiders, and 42.21% retail investors. Ron Bentsur is the largest individual Nuvectis Pharma shareholder, owning 3.25M shares representing 17.69% of the company. Ron Bentsur's Nuvectis Pharma shares are currently valued at $19.97M.

If you're new to stock investing, here's how to buy Nuvectis Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.